2025 Annual Meeting | C189 - Mild Cognitive Impairment/Subjective Cognitive Impairment

Date Wednesday 04/09/25

Time 01:00 PM - 03:00 PM PDT Add To Calendar

Location San Diego Convention Center | 30C-E

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Oscar L. Lopez, MD, FAAN

Topic(s) Aging, Dementia, and Behavioral Neurology

Learning Objectives Participants should become familiar with the construct of mild cognitive impairment (MCI), identify criteria for the diagnosis of MCI, use MCI as clinical syndrome, differentiate underlying causes of MCI for treatment, develop a program for evaluating patients for pharmacotherapy, and evaluate the longitudinal outcome of patients with MCI.

This program is supported in part by an educational grant from Eisai Inc.

CME Available 2.00 CME credits

Program Level Intermediate

Program Tracks Brain Health

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:30 PM PDT	Speaker	TBD Oscar L. Lopez, MD, FAAN
01:30 PM - 02:00 PM PDT	Speaker	MCI Nomenclature in the Era of Anti-amyloid Treatments Ronald C. Petersen, MD, PhD, FAAN
02:00 PM - 02:30 PM PDT	Speaker	Implementation and Management of Anti-amyloid Treatments David J. Gill, MD, FAAN
02:30 PM - 03:00 PM PDT	Discussion	Case Discussions Oscar L. Lopez, MD, FAAN, Ronald C. Petersen, MD, PhD, FAAN, David J. Gill, MD, FAAN

Faculty Disclosures
Oscar L. Lopez, MD, FAAN	Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acumen.
Ronald C. Petersen, MD, PhD, FAAN	Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
David J. Gill, MD, FAAN	Dr. Gill has nothing to disclose.

��ɫ��

��ɫ��